Compare SQM & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SQM | CNC |
|---|---|---|
| Founded | 1968 | 1984 |
| Country | Chile | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.0B | 21.5B |
| IPO Year | 1997 | 2001 |
| Metric | SQM | CNC |
|---|---|---|
| Price | $91.21 | $54.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 16 |
| Target Price | ★ $68.80 | $42.44 |
| AVG Volume (30 Days) | 1.3M | ★ 4.5M |
| Earning Date | 05-26-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.11 |
| Revenue | N/A | ★ $194,777,000,000.00 |
| Revenue This Year | N/A | $8.31 |
| Revenue Next Year | $7.83 | $1.05 |
| P/E Ratio | $39.64 | ★ $15.77 |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $29.36 | $25.08 |
| 52 Week High | $95.46 | $63.42 |
| Indicator | SQM | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 60.44 | 86.78 |
| Support Level | $68.06 | $33.00 |
| Resistance Level | $95.46 | N/A |
| Average True Range (ATR) | 3.84 | 1.88 |
| MACD | 0.04 | 1.71 |
| Stochastic Oscillator | 69.74 | 98.63 |
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.